Hironori Matsunaga
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Long-term administration of the mutant IDH inhibitor DS-1001b suppresses the growth of IDH1-mutant glioma in vitro and in mouse xenograft models and alters epigenetic profiles.
Journal: Acta neuropathologica
Published: August 28, 2025
Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.
Journal: Oncogene
Published: December 20, 2018
A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model.
Journal: Molecular cancer therapeutics
Published: December 06, 2018
IQGAP1 selectively interacts with K-Ras but not with H-Ras and modulates K-Ras function.
Journal: Biochemical and biophysical research communications
Published: January 02, 2014
A validated quantitative liquid chromatography-tandem quadrupole mass spectrometry method for monitoring isotopologues to evaluate global modified cytosine ratios in genomic DNA.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: November 11, 2013
IDH1 and IDH2 have critical roles in 2-hydroxyglutarate production in D-2-hydroxyglutarate dehydrogenase depleted cells.
Journal: Biochemical and biophysical research communications
Published: May 31, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026